Home › Funds › Kynam Capital Management, LP › COGT
Kynam Capital Management, LP position in COGT
COGENT BIOSCIENCES INC · Health Care
Kynam Capital Management, LP reported holding 3,667,097 shares of COGT (COGENT BIOSCIENCES INC) in its Q2 2026 13F filing — a position valued at US$141.9M, representing 7.84% of its reported portfolio and ranking #4 among its reported holdings. Kynam Capital Management, LP has disclosed COGT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Kynam Capital Management, LP's COGT position evolved
Kynam Capital Management, LP first disclosed a stake in COGT in Q3 2023 at 2,210,125 shares (US$21.5M). The position peaked in Q4 2025 at 6,165,223 shares, worth US$219.0M. Across 12 filings, Kynam Capital Management, LP increased the stake 3 time(s), trimmed it 6 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 3,667,097 shares valued at US$141.9M — a reduction of -370,234 shares quarter over quarter.. Notable position changes include a 165% increase in Q4 2023 (shares rose 14% over the following quarter), a 45% increase in Q1 2024 (shares rose 25% over the following quarter), a 35% trim in Q1 2026 (shares were roughly flat over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 2.21M | $21.55M | New |
| Q4 2023 | 5.85M | $34.43M | Add |
| Q1 2024 | 8.50M | $57.12M | Add |
| Q2 2024 | 9.26M | $78.07M | Add |
| Q3 2024 | 9.24M | $99.79M | Hold |
| Q4 2024 | 9.11M | $71.02M | Reduce |
| Q1 2025 | 9.11M | $54.54M | Hold |
| Q2 2025 | 8.49M | $60.98M | Reduce |
| Q3 2025 | 7.89M | $113.25M | Reduce |
| Q4 2025 | 6.17M | $218.99M | Reduce |
| Q1 2026 | 4.04M | $155.40M | Reduce |
| Q2 2026 | 3.67M | $141.92M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About COGT and 13F data
COGT (COGENT BIOSCIENCES INC) is a Health Care company. 59 other funds we track also report a position in COGT — the largest reported positions include Fairmount Funds Management LLC (US$213.0M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$193.7M), TCG Crossover Management, LLC (US$187.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding COGT
- Fairmount Funds Management LLC 5.50M sh · $212.98M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 5.01M sh · $193.74M · Q2 2026
- TCG Crossover Management, LLC 4.85M sh · $187.87M · Q2 2026
- Commodore Capital LP 3.05M sh · $118.03M · Q2 2026
- Octagon Capital Advisors LP 2.35M sh · $90.94M · Q2 2026
- RTW INVESTMENTS, LP 2.31M sh · $89.36M · Q2 2026
- Deep Track Capital, LP 2.00M sh · $77.40M · Q2 2026
- Siren, L.L.C. 1.86M sh · $71.95M · Q2 2026
- Venrock Adviser, LLC 1.64M sh · $63.55M · Q2 2026
- EMERALD ADVISERS, LLC 1.60M sh · $62.05M · Q2 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 1.28M sh · $49.56M · Q2 2026
- Elmind Capital, LP 1.17M sh · $45.31M · Q2 2026
More on Kynam Capital Management, LP
FAQ
How long has Kynam Capital Management, LP held COGT?
Kynam Capital Management, LP has disclosed COGT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Kynam Capital Management, LP's current position in COGT?
As of Q2 2026, Kynam Capital Management, LP holds 3.67M shares of COGT (COGENT BIOSCIENCES INC), valued at $141.92M, representing 7.84% of its reported portfolio and ranking #4.
Has Kynam Capital Management, LP been buying or selling COGT?
In the latest 13F filing (Q2 2026), Kynam Capital Management, LP reduced its position in COGT. The position peaked in Q4 2025 at 6.17M shares.
Which other funds hold COGT?
Other major institutional holders of COGT include Fairmount Funds Management LLC, DEERFIELD MANAGEMENT COMPANY, L.P., TCG Crossover Management, LLC, among 59 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.